what is known already: Morphometrical studies have shown that on the cellular level, impaired spermatogenesis results in a relative enrichment of somatic cell types. However, until now it is not known how this affects transcript levels in gene expression studies. study design, size duration: In this study, 31 testis biopsies from men with different stages of spermatogenic impairment (full spermatogenesis, hypospermatogenesis, meiotic arrest, spermatogonial presence, Sertoli cell-only syndrome, complete tubular atrophy) were used to define reference ratios of somatic transcript enrichment/dilution. The reference ratios were validated on an independent test set of 28 samples and on gene expression data from men with Y-chromosomal microdeletions.
Introduction
Human spermatogenesis is a highly ordered process in which the seminiferous epithelium is populated by different germ cell types such as spermatogonia, primary/secondary spermatocytes and round/elongated spermatids. The germ cells are contrasted with a plethora of somatic testicular cells such as Sertoli cells, Leydig cells, peritubular myoid cells, fibroblasts and a selection of immune cells such as macrophages, lymphocytes and mast cells. As a consequence of the testicular composition, changes in germ cell quantities entail a shift in the relative proportion of the somatic cell types. Changes in somatic cellular quantities are therefore observed in many cases where human spermatogenesis is negatively affected, such as Y-chromosomal microdeletions (Luetjens et al., 2002) , testicular dysgenesis (Guminska et al., 2010) , varicocele (Zukerman et al., 1978) , aging (Johnson et al., 1984) or unknown etiologies leading to idiopathic non-obstructive azoospermia (Kostova et al., 2007; Abdou et al., 2011) .
The advance in methodologies for gene expression profiling in the last decade has offered the potential to unveil and correlate changes in global gene expression with progressing or impaired spermatogenesis. With respect to progressing spermatogenesis, global gene expression changes in the human (Schultz et al., 2003; Ellis et al., 2007) and rodent (Pang et al., 2003; Ellis et al., 2004; Shima et al., 2004) testis are largely driven by the germ cell composition of the seminiferous tubules, resulting in gene expression patterns that correlate with the histological appearance CappalloObermann et al., 2010; von Kopylow et al., 2010) .
As viewed from a perspective of impaired spermatogenesis, the observation of an enrichment in somatic quantities coinciding with decreasing germ cell quantity hallmarks an essential problem in testicular gene expression studies involving samples with different levels of spermatogenic impairment: there is a requirement for reference correction factors that delineate differences in transcript levels as a consequence of increased somatic cell quantities from those that pertain to actual induced gene expression. These correction factors would be applied in cases where a cut-off value is needed to define transcript level up-regulation of somatic transcripts in case of spermatogenic impairment, or conversely, down-regulation in case of progressing spermatogenesis. With respect to existing Bayne et al., 2008; Okada et al., 2008; Zhou et al., 2010) and future multimarker or large-scale analyses of human spermatogenic dysfunction, the relatively large number of potentially regulated somatic genes would optimally be reduced to a more realistic set of genes that do not follow quantitative cellular enrichment but exhibit significant transcriptional regulation.
Since reference correction factors are not defined to date, we employed high-quality microarray data from men with different levels of spermatogenic impairment [full spermatogenesis, hypospermatogenesis, meiotic arrest, presence of spermatogonia, Sertoli-cell-only (SCO) syndrome and tubular atrophy TA)], filtered Sertoli-and Leydig-cell-specific genes by t-tests and Pearson correlation analysis, and calculated reference enrichment/dilution factors for these two cell types for all levels of spermatogenic impairment using robust permutation statistics. These results were aggregated into general ruleof-thumb correction factors to delineate transcript dilution/enrichment from genuine transcriptional regulation.
To validate cellular specificity of the filtered transcripts, we checked their performance on an independent test set, analyzed the functional enrichment [gene ontology (GO)] and cellular localization of the corresponding proteins in a histological database and defined dilution/enrichment ratios in an altered genetic background (Y-chromosomal microdeletions).
Materials and Methods

Microarray data
The reference dilution/enrichment values defined in this study were calculated from Affymetrix GeneChipw microarray data of human spermatogenic impairment, obtained from RNA of testicular biopsies from a testicular sperm extraction procedure at the Department of Andrology, Hamburg. The data are deposited at the EMBL ArrayExpress database (E-TABM-234) and have previously been used to define transcriptional changes in disturbed human spermatogenesis . The probe sets (in case of the Affymetrix platform) were RMA processed, positive (hybridizaton) controls were removed and the backgrounduncorrected data (to avoid loss of transcripts with absent/low abundance in one of the spermatogenic stages) was quantile normalized. This resulted in a list of 54 613 transcripts of which 51 279 were unique and 11 005 contained RefSeq sequences (available from the authors on request).
A total of 31 samples were used for this study, including samples with full spermatogenesis (FS, n ¼ 8), hypospermatogenesis (HS, n ¼ 10), meiotic arrest (MA, n ¼ 5), presence of spermatogonia (SGO, n ¼ 2), SCO syndrome (n ¼ 5) and highly homogeneous complete TA (n ¼ 1). All samples are named in Supplementary data S1 by the scheme FS01 (i.e. first sample with full spermatogenesis) and so forth. The mapping of sample names to the corresponding array database names is found in Supplementary data S1, 'sample mapping'.
Two more microarray data sets were included in the study: (i) a data set of 28 samples (SCO, n ¼ 5; MA, n ¼ 5; HYS, n ¼ 6; FS, n ¼ 12) from Feig et al. (2007) , GEO database GSE4797 and (ii) microarray data of Y-chromosomal-induced transcriptional changes from CappalloObermann et al. (2010) , GEO database GSE21613. Both data sets were acquired with the Codelink TM platform (GE Healthcare, Piscataway, NJ, USA). While the former was employed as an independent test set to validate the defined ratio values, the latter was used to address the question of ratios in the background of a genetic alteration with testicular effects. Filtering of genes from our initial data in these two data sets was conducted using intersecting unique OGS (Official Gene Symbols) with averaging if the same OGS occurred more than once. Ratios from these two data sets were obtained by the same permutation approach as the initial set.
Correction values for testicular gene expression studies Selection of Sertoli-and Leydig-cell-specific genes Sertoli cell-specific genes were filtered between the sample with complete TA and the averaged values of the five Sertoli-cell-only samples. Histologically, the only difference between these two phenotypes is the presence of Sertoli cells in the seminiferous tubules. As only one TA sample was available, we used a very stringent cut-off value of at least 30-fold increase in transcript levels from TA to SCO, and obtained 54 genes that met this criterion (Supplementary data S1, 'Sertoli cell markers, raw').
Leydig cell-specific genes were filtered by a Pearson correlation coefficient of r .0.85 to all samples with the STAR (Steroid Acute Regulatory) transcript as a matching template. In testis, the STAR transcript assists in mitochondrial cholesterol translocation and is exclusively found in Leydig cells (Pollack et al., 1997) . Using the Pearson correlation as a metric to identify transcripts that exhibit highly similar expression changes throughout all individual samples (Mansson et al., 2004) , we obtained 332 genes that are enriched for Leydig cell specificity. Filtered transcripts, Pearson correlation coefficients, as well as raw and Bonferroni-adjusted P-values from a correlation test can be found in Supplementary data S1, 'Leydig cell markers, raw'.
To corroborate our defined ratios, we conducted correlation filtering similar to the STAR-based approach (see above) using SPINLW1/SOX9 for Sertoli cell markers and INSL3/FTL for Leydig cell markers. Here, an equal number of genes as in the above setup were used to calculate reference ratios. Furthermore, these markers were used solely for calculating reference ratios in order to validate the robustness of ratio values when comparing multiple against single genes.
Permutation analysis of expression ratios
The estimation of expression ratios between the different spermatogenic subtypes was based on robust permutation statistics (Lunneborg, 1999) as described below. This has the major advantage of not depending on a known statistical distribution for the data and can be used for unbalanced designs with different sample sizes.
Taken two levels A, B of spermatogenic impairment, for microarray data of group A with samples A ¼ (1, 2, 3, . . . , i) and group B with samples B ¼ (1, 2, 3, . . . , j), we defined a vector R for the ratios of all possible pairwise combinations by enumerating these for each gene (1, 2, 3, . . . , k):
with A i,k and B j,k being the exponentiated microarray value x (i.e. 2 x ), if microarray data were previously log 2 transformed. This way, we obtained i × j × k combinations, i.e. 4320 ratio values when comparing FS (i ¼ 8) with HYS ( j ¼ 10) using Sertoli cell-specific genes (k ¼ 54). For robust and outlier-resistant statistics, we calculated the median (med) as the location metric and median absolute deviation (mad) as the scale metric for vector R containing all ratio combinations:
where the median med is the 50th percentile and the median absolute deviation mad the median of the absolute residuals of all data values from the data's median. Permutation statistics were performed in the open-source statistical programming environment R (www.r-project.org). Rule-of-thumb values were finally calculated by averaging the Sertoli and Leydig cell ratio median values and rounding up to the next half integer.
GO term functional enrichment analysis
GO terms for the 54 Sertoli and 332 Leydig cell-specific genes were analyzed with respect to functional enrichment using the TIGR MeV 4.8.0 software (http://www.tm4.org/mev/) and the EASE cluster module. Over-representation analysis was conducted using Fisher's exact test and stringent Bonferroni correction. Only GO terms with a P value of ,0.05 were considered as significant, and those with the lowest P-values are displayed in red/yellow in the GO term tree.
Validation of cellular specificity by histochemical database analysis
The 'Human Protein Atlas Database' (Uhlen et al., 2010; www. proteinatlas.org) was browsed with the top 20 Sertoli cell and top 20 Leydig cell-specific genes for which immunohistochemical data were available in the database and analyzed with respect to cellular localization within the testis. A semi-quantitative heatmap table was compiled that summarizes the relative expression levels for each of these genes in Sertoli cell nuclei, Sertoli cell cytoplasm, Leydig cell nuclei, Leydig cell cytoplasm, spermatogonia, spermatocytes and spermatids (Supplementary data S3).
Results
The estimation of realistic and robust reference values for somatic transcript dilution/enrichment in altered human spermatogenesis is based on the selection of genes that pertain to the two most important testicular somatic cell types: the Sertoli and the Leydig cells. Transcripts for these two cell types needed to be defined so that their relative expression values can be monitored within different spermatogenic levels. For this, it was necessary to extract a set of cell type-specific transcripts which are in the optimal case specific to, or at least highly enriched, in the corresponding cell type. In principle, literature searches can bring up a reasonable number of cell type-specific transcripts. Yet to acquire a considerable number of specific and enriched transcripts, we found it feasible to investigate existing microarray data from biopsies of men with different levels of spermatogenic impairment. Two different approaches were pursued to filter Sertoli cell-and Leydig cell-specific transcripts from the microarray data: Firstly, expression data from a biopsy presenting complete TA with a highly homogeneous phenotype (lack of Sertoli cell foci) was compared with those from biopsies with SCO syndrome using a stringent cut-off value of at least 30-fold transcriptional induction. Secondly, and because no human testicular phenotypes exist in which the only cellular difference is the presence/absence of Leydig cells, we used an expression correlation approach to filter Leydig cell-specific genes. Using Pearson correlations as a metric to filter transcripts that display a similar expression pattern in all individual samples in comparison with a 'template transcript' can result in a set of transcripts that is massively enriched with respect to the same function, co-regulation and cellular location (Mansson et al., 2004) . Following this paradigm, the STAR transcript which is exclusively found in Leydig cells of the human testis (Pollack et al., 1997) was used as a correlation template for the filtering procedure. With these two different approaches, we obtained 54 putative Sertoli cell-specific and 332 putative Leydig cell-specific transcripts (Supplementary data S1). Caution must be taken in the term 'specific', as the filtered transcripts may not necessarily be exclusive to the corresponding cell type and could also show expression in germ cells. However, when expression values of the 54 Sertoli cell transcripts are displayed in detail (Fig. 1A) , it is evident that after the massive increase from TA to SCO (due to the filtering procedure between these two phenotypes), the relative expression levels gradually decline with increasing germ cell differentiation (SGO ≥ MA ≥ HYS ≥ FS). This accounts for the majority of genes with a few exceptions. This expression profile was a first indication that the filtered transcript set is highly enriched for Sertoli cell specificity, as expression levels would gradually increase with progressing germ cell differentiation when also expressed in germ cells. Similar to the Sertoli cell-specific transcript set, the 332 putative Leydig cell-specific transcripts filtered by high correlation to the STAR profile gave a general pattern of declining expression levels with increasing germ cell differentiation (Fig. 1B) , also with only a few exceptions. As the problem of multiple testing also applies to correlation filtering, we calculated raw and Bonferroni-adjusted P-values from the Pearson test statistic. The adjusted P-values were in a region of 2.43E211 to 7.87E25, so that filtering these genes by random high-correlation events is unlikely (Supplementary data S1, 'Leydig cell markers, raw').
To compare changes in the expression levels of these two cell types and to define general reference values for somatic transcript dilution/ enrichment in progressing/impaired human spermatogenesis, we used a computation-intensive permutation approach in which ratios for all pairwise combinations of spermatogenic levels for each of the genes were calculated and summarized by robust and outlier-insensitive statistics (median + median absolute deviation). These values are given as a crosstable in Fig. 1C , with green and orange cells defining the ratios for Sertoli and Leydig cell transcripts, respectively. This crosstable constitutes the core result of the study as it contains the reference values we aimed to define.
It can be read and interpreted as follows: when comparing the Sertoli cell gene expression of a testicular sample from a man presenting full testicular spermatogenesis with that of a man with SCO syndrome, expression levels are increased overall (enriched) by 2.40 (+0.87) fold in the latter. With respect to Leydig cell-specific transcripts, this comparison gives a 2.69 (+1.13) fold increase. Conversely, and viewed from successfully progressing spermatogenesis, these Correction values for testicular gene expression studies values reflect a 2.40 (+0.87) fold and 2.69 (+1.13) fold decrease (dilution) in Sertoli and Leydig cell expression levels, respectively, when full testicular spermatogenesis is compared with SCO syndrome. Ratios using either TA or SGO samples must be considered with some caution since the low sample size (n ¼ 1, n ¼ 2, respectively) might not result in realistic estimates. However, their ratios fit well inbetween those with higher/lower spermatogenic impairment.
Small differences in the ratio values for Sertoli and Leydig cell transcripts can be observed (as for the two ratios above). Generally, the ratios for both cell types diverge by 5 -15%, but confidence intervals overlap (data not shown), so that the differences are not statistically significant. We aggregated these values to define simpler 'rule of thumb' values ( Fig. 1D) that are applicable for a wider range of germ cell composition differences (see the heading 'Discussion').
The gradual decline in Sertoli cell-and Leydig cell-specific transcript expression throughout progressing spermatogenesis was a first indication of having filtered a set of transcripts which is highly enriched/specific to the corresponding cell type. To strengthen this argument further, we used three more approaches to validate the genes, their derived ratios and cell specificity.
Firstly, we filtered the same genes from an independent microarray data set (Codelink TM platform) of human spermatogenesis (test set) from Feig et al. (2007) . Due to incomplete overlap of the different data sets, this resulted in a set of 21 genes for Sertoli and 202 genes for Leydig cells. Ratios were calculated by the same permutation approach as for our initial data (training set) and compared. Calculated ratios from the 'test set' displayed values in a region of +0.5 of the 'training set' when comparing Sertoli cell transcripts ( Fig. 2A , dark green versus light green bars) or Leydig cell transcripts (Fig. 2B , dark orange versus light orange bars). The most pronounced difference was in SCO/FS ratios, which to our experience pertains to the different fluorescence dynamics of the two microarray platforms in case of large expression differences.
To confirm that using a large group of Sertoli/Leydig cell-specific transcripts presents an advantage over using single reference genes to define reference ratios, known marker genes from the literature were selected [Sertoli cells: SPINLW1 (Eppin), Wang et al., 2007 and SOX9, Morais da Silva et al., 1996; Leydig cells: INSL3, Adham et al., 1993 and FTL, Santambrogio et al., 2007] and these used for (i) defining ratios based on a correlation filtering approach as already conducted with the STAR transcript or (ii) based on ratios obtained from single transcripts alone. Correlation filtering of transcripts based on these four marker genes using the same number of genes (54 genes for SPINLW1 and SOX9, 332 genes for INSL3/FTL) resulted in ratios that were similar to those obtained from using TA/SCO-filtered Sertoli cell markers or STAR-filtered Leydig cell markers (Supplementary data S4A, S5A, respectively). Using these markers solely, the calculated ratios differed significantly from those of our initial marker sets, as shown with the higher overall deviance from the reference data set to unity (Supplementary data S4B, 5B), with the exception of FTL, which performed better in the latter case.
Secondly, we mined a GO term database with our filtered transcripts with respect to functional over-representation. It would be expected that a successful enrichment in Sertoli and Leydig cell- Figure 2 Comparison of enrichment/dilution values as given in Fig. 1 (here termed 'Training set', darkgreen) with an independent microarray study of impaired human spermatogenesis  here termed 'Test set', light green) and with a microarray study on the effect of Y-chromosomal microdeletions on the testicular transcriptome (Cappallo-Obermann et al., 2010) using a 'control group without deletions' (dark gray) and a 'group with AZF deletions' (light gray). Barplots depict the median + mad values of the different enrichment/dilution factors as in Fig. 1 for the group of Sertoli cell markers (A) and Leydig cell markers (B), filtered by the intersection of the two other data sets. No TA and SPG samples were available in the Test set and in the group with AZF deletion samples and hence are not displayed. Sample names and corresponding database entries can be found in Supplementary data S1, 'Sample mappings'.
specific genes should correlate with the specific functions of these cells in the human testis. Indeed, for Sertoli cells functional categories such as male sex determination (due to the presence of SOX9 and DMRT1 in the data) and glutamate metabolism (glutamate dehydrogeneses GLUD1 and GLUD2) were the GO terms with the lowest P-values for over-representation (Supplementary data S2, left panel). For Leydig cell transcripts, 9% (23 of 259 found in the database) of these are involved in steroid metabolism, thus giving the corresponding GO term the highest statistical significance (Supplementary data  S2, right panel) .
Thirdly, the Human Protein Atlas was browsed for the top 20 Sertoli-and Leydig cell-specific transcripts for which immunohistochemical data were available in the database. Most of these transcripts exhibited their largest protein expression in the corresponding cell type's nucleus or cytoplasm (Supplementary data S3) , but weak-to-moderate staining was also often encountered in germ cell stages. If signals were weak, they displayed a pattern common for nonspecific staining, but signal specificity cannot be excluded. In general, Leydig cell expression was overall stronger and specific, while 80% of the corresponding proteins in Sertoli cells were also expressed weakly to moderately in other cell types. INSL3/FTL, used in this study to validate the correlation filtering approach of Leydig cell markers, were also included and displayed high Leydig cell specificity.
The testicular volume correlates to a large extent with the germ cell content of the testis (Bujan et al., 1989; Ezeh et al., 1998) . To correlate our calculated ratios with testicular volume, we compared the reference ratios of Fig. 1 to the averaged testicular volumes of the same patients from which the microarray data were acquired. As expected, increasing levels of spermatogenic impairment resulted in a decrease in testicular volumes in the different groups (Fig. 3A) . A comparison of the averaged (for each level of spermatogenic impairment) testicular volumes to the calculated Leydig cell marker ratios of the table in Fig. 1 (Fig. 3B) showed a high linear correlation of these two parameters (R 2 ¼ 0.991). However, when interrogating selected samples with similar testicular volumes (FS01: 20 ml; HYS02: 18 ml; MA01: 18 ml; SCO04: 18 ml) for Sertoli cell (Fig. 3C) or Leydig cell (Fig. 3D ) transcript enrichment ratios, these are within the same region as those defined in Fig. 1 (Fig. 3E) . Hence, the observation of transcript enrichment in the presence of comparable testicular volumes indicates that on average, expression ratios correlate with testicular volume, but for single samples there may be exceptions (see the heading Discussion).
As a final aspect, we investigated if obtained reference ratios are consistent for samples in which spermatogenic impairment is a consequence of a genetic alteration. It may be possible that a genetic defect induces significantly altered transcription in somatic cells, especially germ cell-supporting Sertoli cells. Here, Klinefelter syndrome and Ychromosomal microdeletions are the most prevalent genetic defects leading to spermatogenic dysfunction (Dohle et al., 2002) . To date, no global gene expression data for Klinefelter-induced transcriptional changes is available. However, in a recent study we investigated transcriptional changes in men with AZFbc/AZFc deletions (CappalloObermann et al., 2010) . We used the data to filter intersecting genes (20/98 genes for Sertoli and Leydig cells, respectively) and calculate permutation-based ratios similar to our initial training and test data sets. For those combinations for which data were available (MA/HYS, SCO/HYS, SCO/MA), the control group exhibited ratios for Sertoli ( Fig. 2A , dark gray bars) and Leydig (Fig. 2B , dark gray bars) cell markers that corresponded well with the test set, which was obtained with the same microarray platform (Codelink). Contrasting this, ratios obtained from the group of samples with AZFbc/AZFc deletions displayed markedly decreased ratios, especially when SCO samples were used ( Fig. 2A/B , light gray bars).
Discussion
The partitioning of the testis into germ cells and somatic cells implies a shift in relative somatic cellular quantities when germ cell quantities are changing. This shift results in an increase in somatic cellular quantities in impaired spermatogenesis, or conversely, in a relative decrease when spermatogenesis is progressing. Changes in somatic cell quantities are therefore observed in many cases where human spermatogenesis is negatively influenced. A classical approach to quantifying cellular proportions is histological morphometry with different parameters such as tubular diameter/percentage SCO tubules (Luetjens et al., 2002; Abdou et al., 2011) , cell counts per unit tubular wall/ cell counts per Sertoli cell (Zukerman et al., 1978) , germ cell/Sertoli cell ratio (Johnson et al., 1984) and 'areal fraction' (Guminska et al., 2010) . There are also other non-histological approaches such as the estimation of cell type proportions by flow cytometry (Kostova et al., 2007) . Adding to the fact that all investigations demonstrate a germ cell-dependent relative proportion of somatic cell quantities, these histological observations also have a direct implication for studies of altered transcription in the human testis: if statements about induced/repressed gene expression in somatic cells are made, it is important to delineate actual up-/down-regulation from transcript enrichment/dilution due to increased/decreased relative proportions of the corresponding somatic cells. As hundreds of potentially regulated genes are commonly filtered in large-scale gene expression studies of the human testis (Schultz et al., 2003; Chalmel et al., 2007; Ellis et al., 2007; Feig et al., 2007) , we believe that this point has gained increasing importance. In the special case of impaired spermatogenesis (Ellis et al., 2007; Spiess et al., 2007; Bayne et al., 2008; Okada et al., 2008; Cappallo-Obermann et al., 2010; Gatta et al., 2010; Cavalcanti et al., 2011) , it is necessary to separate genuine somatic cell gene regulation from simple transcript enrichment. We are only aware of one gene expression study in which a somatic transcript dilution effect is actually mentioned (Ellis et al., 2004) . Interpretations in these studies are largely based on differential gene expression, so that defining cut-off values based on transcript levels that serve as 'decision borders' for dilution/enrichment versus gene regulation seem feasible. To date, no decision criteria are available. In principle, these cut-off values might be defined by a small set of well-investigated somatic transcripts. However, we could demonstrate in this study that when using a larger cohort of transcripts, more realistic average values can be estimated, in particular when robust statistical methods such as permutation-based approaches are employed. Two sets of Sertoli-and Leydig-cell-specific transcripts (54 and 332, respectively) were used in defining general somatic cell reference ratios for different levels of spermatogenic impairment. Since they were filtered by two completely different approaches (differential expression between TA/SCO and correlation with the STAR transcript), it was imperative to validate specificity or at least high enrichment for these two cell types. This was achieved by analyzing different mandatory features of the filtered transcripts: (i) applying the filtered transcripts on an independent microarray data set of impaired spermatogenesis or using known Sertoli and Leydig cell markers to filter transcripts should result in similar ratio values, (ii) GO term analysis for functional over-representation should correlate well with Sertoli cell and Leydig cell function and (iii) the corresponding proteins should be localized exclusively to Sertoli and Leydig cells when browsing a histological protein expression database. In principle, all these criteria could be met. The largest deviation from potential specificity was observed in the pattern of protein expression as deduced from the histological database. Here, .80% of the proteins displayed moderate histological signals also in other (mostly germ) cell types. However, in light of a complete lack of overlap of Sertoli and Leydig cell transcripts with germ cell expressed transcripts (data not shown), specificity of the protein signals in germ cells is questionable.
Despite these few exceptions, the cell types that pertained to the filtered transcripts corresponded strongly with their functional overrepresentation (GO terms). For Sertoli cells, male sex differentiation and also glutamate metabolism, the latter being essential for germ cell support with lactate (Spanaki et al., 2010) , are mostly testis specific functions. For Leydig cells, steroidogenesis is clearly the prevailing function (Huhtaniemi and Toppari, 1995) . Taken together, these results support that our filtered gene lists are significantly enriched with respect to Sertoli-and Leydig-cell specificity.
A remark has to be made on how to apply the reference ratios: the values in Fig. 1C reflect those of the robust average (median) and robust version of the standard deviation (median absolute deviation, mad) obtained from permutating the ratios of all genes in each set. These are too conservative to be used as general cut-off criteria. Hence, we defined more general values by averaging the Sertoli and Leydig cell median ratios and rounding up to the next half integer (i.e. (1.72 + 1.15)/2 ¼ 1.435 ≥ 1.5). These rule-of-thumb values in Fig. 1D should be used as follows: (i) in case of a fairly homogeneous germ cell content (histology) of the samples one should use the values of Fig. 1D , but (ii) in case of variable histological appearance of at least one of the samples (i.e. when comparing a homogeneous MA sample with an SCO sample containing a significant number of spermatogenic foci), a less stringent value may be appropriate and therefore 0.5 should be subtracted.
Reference ratios calculated from the samples with Y-chromosomal microdeletions (YCMD) showed significantly smaller values than those from our 'training set'. In principle, two different factors could contribute to this finding: (i) Sertoli cell markers are significantly downregulated in the presence of YCMD as has been shown for Inhibin B (Frydelund-Larsen et al., 2002) , or (ii) the somatic cellular enrichment is less pronounced because of a slightly greater average tubular diameter of YCMD samples compared with infertile controls (Luetjens et al., 2002) .
Interestingly, ratios obtained from real-time PCR analysis of FSH/ LH receptor transcripts in Sertoli and Leydig cells correspond well with those described here (data not shown), demonstrating that our defined reference values seem to be applicable to other transcriptional profiling methods (i.e. real-time PCR, RNA sequencing).
To the end, we wish to emphasize two small aspects of this study that are not directly related to the definition of reference dilution/enrichment ratios.
First, we were surprised by the very high correlation of our transcript-based reference ratios to the averaged testicular volumes of the same patients from which the expression profiles were obtained. However, in light of having filtered transcripts that are stably expressed and only diluted/enriched by the presence of germ cells, and assuming linearity of microarray signals to transcript numbers, calculated ratios should be exactly proportional to cell number ratios. Hence, the reference ratios additionally define a factor for Sertoli and Leydig cell numbers in the biopsy from which they were obtained. Since constant amounts of RNA are used for microarray hybridizations, the ratios also apply to approximately the same initial biopsy volumes. Taken together, we suggest that under the assumption of cell specificity (as is the case here) and lack of differential expression, averaged expression levels of our filtered transcripts can be viewed as a molecular variant of morphometry that directly correlates transcript numbers with cellular proportions in a complex three-dimensional tissue structure such as the testis. Interestingly, 'points' obtained from counting Leydig cells in FS and SCO biopsies has lead to ratios highly similar to ours ( 2.2; Guminska et al., 2010) , largely as a consequence of an increased number of tubules and interstitial area when the tubular diameter decreases with germ cell loss (Luetjens et al., 2002 , Abdou et al., 2011 . Similarly, somatic (2n) cells counted by flow cytometry indicate a 2-2.5-fold increase in proportion when comparing FS with SCO (Kostova et al., 2007) . Notwithstanding, we also observed transcript enrichment for selected samples with similar testicular volumes. Since the ratios in these samples indicated an enrichment of Sertoli and Leydig cell markers (and hence cellular quantities), other cellular factors must exist that keep the testicular volume constant with a concomitant increase in somatic proportions. Here, the thickness of the lamina propria and differences in tubular diameter depending on the etiology of SCO, as mentioned for the YCMD samples, may play a role (Luetjens et al., 2002) .
Secondly, and as a result of our two different filtering approaches, this study provides previously unavailable large-scale transcript data enriched for human Sertoli-and Leydig-cell-specific function, which may also prove useful for other investigations.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
